Biovara is a UK based drug development company focused on the rapid development of a novel treatment for lung cancer cough (LCC) – an unmet medical need with a multi-billion-dollar addressable market. We are working with the aprepitant molecule that has known properties in the treatment of lung cancer cough. We have successfully addressed major problems with dosing and bioavailability and confirmed safety of a lipid formulation (LipAprep) at doses likely to be necessary to treat lung cancer cough.
Company Details
- Industry
- Pharmaceutical Manufacturing
- NAICS
-
Pharmaceutical and Medicine ManufacturingMedicinal and Botanical ManufacturingPharmaceutical Preparation ManufacturingIn-Vitro Diagnostic Substance ManufacturingBiological Product (except Diagnostic) Manufacturing
- Website
- http://www.biovara.co.uk
Biovara Questions
Biovara's website is http://www.biovara.co.uk
Biovara's LinkedIn profile is https://www.linkedin.com/company/biovara
Biovara's industry is
Pharmaceutical Manufacturing
Biovara's top competitors are
Oxilio,
Fmrp (Fundamentals Of Medical Research & Publication).
Biovara's categories are Pharmaceutical Manufacturing
